A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia

American Journal of Geriatric Psychiatry

Volumn 21, Issue 1, 2013, Pages 78-87

  Ismail, Zahinoor ^a,b   Emeremni, Chetachi A ^c   Houck, Patricia R ^c   Mazumdar, Sati ^c   Rosen, Jules ^d   Rajji, Tarek K ^a   Pollock, Bruce G ^a,d   Mulsant, Benoit H ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Agitation; Alzheimer disease; Behavioral disturbance in Alzheimer disease; BPSD; Clinical trials; Dementia; E BEHAVE AD; NBRS; Neuropsychiatric symptoms; NPI; NPS; Pharmacotherapy; Psychosis; Rating scales

Indexed keywords

CITALOPRAM; RISPERIDONE;

AGED; AGITATION; ARTICLE; BEHAVIOR DISORDER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMPIRICAL BEHAVIORAL RATING SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROBEHAVIORAL RATING SCALE; NEUROPSYCHIATRIC INTERVIEW; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

EID: 85027939178     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2012.10.013     Document Type: Article

References (36)

1. Ballard C, Brown R, Fossey J, et al: Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial). Am J Geriatr Psychiatry 2009; 17:726-733
2. Pollock BG, Mulsant BH, Rosen J, et al: A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry 2007; 15:942-952
3. Pollock BG, Mulsant BH, Rosen J, et al: Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002; 159:460-465
4. Ujkaj M, Davidoff DA, Seiner SJ, et al: Safety and efficacy of electro-convulsive therapy for the treatment of agitation and aggression in patients with dementia. Am J Geriatr Psychiatry 2012; 20:61-72
5. Wang LY, Shofer JB, Rohde K, et al: Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry 2009; 17:744-751
6. Ballard CG, Gauthier S, Cummings JL, et al: Management of agitation and aggression associated with Alzheimer disease. Nature Rev 2009; 5:245-255
7. Gauthier S, Cummings J, Ballard C, et al: Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr 2010; 22: 346-372
8. Schneider LS, Tariot PN, Dagerman KS, et al: Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Eng J Med 2006; 355:1525-1538
9. Jeon YH, Sansoni J, Low L, et al: Recommended measures for the assessment of behavioral disturbances associated with dementia. Am J Geriatr Psychiatry 2011; 19:403-415
10. Culo S, Mulsant BH, Rosen J, et al: Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial. Alzheimer Dis Assoc Disord 2010; 24:360-364
11. Alexopoulos GS, Abrams RC, Young RC, et al: Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23:271-284
12. Lee PE, Gill SS, Freedman M, et al: Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 2004; 329:75
13. Rodda J, Morgan S, Walker Z: Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine, and galantamine. Int Psychogeriatr 2009; 21: 813-824
14. Auer SR, Monteiro IM, Reisberg B: The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale. Int Psychogeriatr 1996; 8:247-266
15. Reisberg B, Auer SR, Monteiro IM: Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int Psychogeriatr 1996; 8(suppl 3):301-308; discussion 351-354
16. Harwood DG, Ownby RL, Barker WW, et al: The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry 1998; 13:793-800
17. Mulsant BH, Mazumdar S, Pollock BG, et al: Methodological issues in characterizing treatment response in demented patients with behavioral disturbances. Int J Geriatr Psychiatry 1997; 12: 537-547
18. Kastango KB, Kim Y, Dew MA, et al: Verification of scale subdomains in elderly patients with dementia: a confirmatory factor analytic approach. Am J Geriatr Psychiatry 2002; 10:706-714
19. Levin HS, High WM, Goethe KE, et al: The neurobehavioural rating scale: assessment of the behavioural sequelae of head injury by the clinician. J Neurol, Neurosurg Psychiatry 1987; 50:183-193
20. Sultzer DL, Levin HS, Mahler ME, et al: Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc 1992; 40:549-555
21. Sultzer DL, Levin HS, Mahler ME, et al: A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 1993; 150:1806-1812
22. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 62:799-812
23. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
24. Cummings JL: The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48:S10-S16
25. Aalten P, de Vugt ME, Lousberg R, et al: Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Demen Geriatr Cognitive Disorders 2003; 15:99-105
26. Frisoni GB, Rozzini L, Gozzetti A, et al: Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord 1999; 10:130-138
27. Fuh JL, Liu CK, Mega MS, et al: Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. Int Psychogeriatr 2001; 13:121-128
28. Gauthier S, Wirth Y, Mobius HJ: Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int J Geriatr Psychiatry 2005; 20:459-464
29. Hollingworth P, Hamshere ML, Moskvina V, et al: Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J Am Geriatr Soc 2006; 54: 1348-1354
30. Mirakhur A, Craig D, Hart DJ, et al: Behavioural and psychological syndromes in Alzheimer's disease. Int J Geriatr Psychiatry 2004; 19:1035-1039
31. Spalletta G, Musicco M, Padovani A, et al: Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry 2010; 18:1026-1035
32. Vilalta-Franch J, Lopez-Pousa S, Turon-Estrada A, et al: Syndromic association of behavioral and psychological symptoms of dementia in Alzheimer disease and patient classification. Am J Geriatr Psychiatry 2010; 18:421-432
33. Guy W: ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publication No. ADM 76-338). Rockville, MD: US Department of Health and Human Services, 1976
34. Cochran WG: The comparison of percentages in matched samples. Biometrika 1950; 37:256-266
35. Fleiss JL, Levin B, Paik MC: Statistical Methods for Rates and Proportions. Third Edition. Hoboken, NJ, Wiley, 2003
36. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845